Celastrol, which is a triterpene puriˆed from Celastraceae plants, has anticancer and anti-in‰ammatory activities. In this study we investigated to clarify whether celastrol can induce apoptosis in a human leukemia HL-60 model system. Celastrol was found to induce apoptosis, and the rank order of the potency of celastrol and its derivatives to induce internucleosomal DNA fragmentation was found to be celastrolÀcela-H :the other derivatives＝vehicle control. Many anticancer agents are known to possess the ability to inhibit topoisomerase II, so the inhibitory activities of celastrol and its derivatives on topoisomerase II were also explored. The rank order of the inhibitory activity was found to be celastrolÀetoposideÀcela-H, indicating that the apoptosis-inducing activities of cela derivatives correspond to their inhibitory activities on topoisomerase II. These data suggested that celastrol may cause its eŠects such as anticancer activity by the mechanism of apoptosis along with topoisomerase II inhibition.
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Key words: celastrol; derivative; apoptosis; topoisomerase II; HL-60 cells Extracts of Celastraceae plants have been used to treat autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus (SLE), chronic nephritis, allergic conjuctivitis and rhinitis, and asthma.
1) These plants produces triterpene compounds such as celastrol.
2) Celastrol has been reported to have antitumor activity, antitumor promoting activity, antiin‰ammatory activity, suppression of adjuvant arthritis, suppression of TNF-a and IL1-b, decrease of the induced expression of class II MHC molecules, and inhibition of NF-kB activation, NO production, and lipid peroxidation. [3] [4] [5] [6] [7] [8] However, the mechanism of celastrol-induced eŠects remains poorly understood. DiŠerent classes of anticancer drugs trigger apoptosis. 9, 10) Immunomodulatory agents was also reported to trigger apoptosis. 11, 12) In addition, apoptosis inducers such as etoposide are known to inhibit topoisomerase II activity. 9) Topoisomerase inhibitors are of immense interest, as these groups of compounds constitute the bulk of anticancer compounds with clinical importance. The topoisomerase inhibitors are generally classiˆed into two classes: the class I inhibitors stabilize formation of enzyme-DNA covalent complexes, the`cleavable complex' and are termed`topoisomerase I poisons'. The class II inhibitors interfere with the formation of the covalent complex and inhibit only the catalytic activity of the enzyme. 13) This paper reports for theˆrst time that celastrol was able to induce apoptosis in the human leukemia HL-60 system. Furthermore, we found that celastrol was a potent inhibitor of topoisomerase II in vitro.
Materials and Methods
Materials. Celastrol and its derivatives (structures: Fig. 1 ) were prepared and puriˆed according to procedures reported previously.
3) The purities of these triterpenes were more than 99z, as judged by 1 H and 13 C NMR analysis. An annexin-V-FITC kit was purchased from Bechman Coulter. (Hialeah, FL). Topoisomerase I, a topoisomerase I drug kit, topoisomerase II, and a topoisomerase II drug kit were from Topogen (Columbus, OH). Cell culture. The HL-60 cell line used in this study was obtained from Riken Cell Bank (Tsukuba, Japan) and routinely cultured under a humidiˆed atmosphere of 5z CO 2 -95z air at 379 C in RPMI 1640 medium (Asahi Technoglass, Tokyo, Japan) supplemented with 10z heat-inactivated fetal calf serum, 2 mM L-glutamine, penicillin (100 units W ml), and streptomycin (100 mg W ml).
Detection of DNA fragmentation by gel electrophoresis. DNA fragmentation was measured as previously described. 12) In brief, after treatment with celastrol, 10 6 cells were lysed with 110 ml of lysing buŠer in an ice bath for 20 min. After centrifugation (16,000×g, 30 min, 49 C), 100 ml of supernatant was mixed with 2 ml of RNase (20 mgW ml) and incubated at 379 C for 1 h, followed by incubation with 400 mg W ml of proteinase K at 379 C for 1 h. Fragmented DNA was precipitated with isopropanol. The DNA (corresponding to 9.1×10 4 cells W lane) was electrophoresed on a 2z agarose gel in TBE buŠer. Bands were stained with ethidium bromide.
Flow cytometric measurement of the percentage of apoptotic cells. Annexin-V combines phosphatidylserine expressed on the surface of cells at the early stage of apoptosis. 14) Late apoptotic cells were also distinguished by their ability to take up propidium iodide (PI). Live cells were those staining negatively for annexin-V-FITC and PI (z of cell survival). In order to measure the percentage of apoptotic cells, annexin-V W PI double staining was done according to the manufacturer's protocol (Annexin-V-FITC kit, Beckman Coulter). Flow cytometry was done with an EPICS XL ‰ow cytometer and System II software (Beckman Coulter). Sample size was set at 20,000 counts.
Assay for topoisomerase II inhibition in vitro. The assay for catalytic inhibition of topoisomerase II measures decatenation of highly catenated kinetoplast DNA (kDNA) networks by puriˆed topoisomerase II. The total reaction volume of 20 ml included decatenation assay buŠer (10 mM Tris-HCl, pH 7.9, 50 mM KCl, 50 mM NaCl, 4 mM MgCl2, 0.1 mM EDTA, 0.5 mM ATP, 15 mg W ml BSA, 1.5 mM 2-mercaptoethanol), and kDNA (32 ng W reaction). Reactions were started by addition of 1.32 units of topoisomerase II and the mixture were incubated at 379 C for 30 min. Reactions were stopped by the incubation at 379 C for 15 min after the addition of 2 ml of 10z SDS and 2 ml of proteinase K (600 mg W ml). The 1 W 10 volume of loading solution (50z glycerol and 1 W 2×TAE) and 20 ml of phenol-chloroform was added to the reaction mixture and mixed for 5 min. The supernatants were obtained after centrifugtation and electrophoresed in 1z agarose submarine gels in the TAE electrophoresis buŠer (40 mM Tris acetate, pH 8.0, 1 mM EDTA) at 8.5 volts W cm for 90 min. After staining with GelSter (Cambrex, East Rutherford, NJ), the bands of kDNA and free DNA circles were visualized at 505 nm by FMBIO Multi-View (Takara Bio, Kyoto). The inhibitory activity (IC 50 ) was deˆned as the amount of inhibitor causing a decrease of decatenated kDNA concentration by 50z.
Results

Celastrol can induce internucleosomal DNA fragmentation in HL-60 cells
In this study, agarose gel electrophoresis was used to assess the degradation pattern of nuclear DNA in celastrol-induced apoptotic cell death. As shown in Fig. 2A , a substantial amount of fragmented DNA of ¿180 bp in ladder form was produced at 0.88 mM celastrol. The course of DNA fragmentation caused by celastrol showed that deˆnite DNA fragmentation appeared 3 h after administration and reached a maximum at 6 h (Fig. 2B) .
To conˆrm further that celastrol-treated cells were in the process of apoptosis, we also measured the incidence of apoptotic cells as assessed by annexin-V W PI through ‰ow cytometry (Fig. 3) . Cells undergoing apoptosis quickly showed an increase in annexin-V binding, but excluded PI (annexin-V positive W PI negative; early apoptosis). At later times, the percentage of PI-staininig cells gradually increased (annexin-V positive W PI positive; late apoptosis), because cells lose the ability to exclude PI at the stage of late apoptosis. From the ‰ow cytometric data, it was shown that the percentage of annexin-V-binding cells (Fig. 3) corresponded to the magnitude of DNA fragmentation (Fig. 2B) .
Taken together, it is indicated that celastrol had the ability to induce apoptosis.
EŠects of celastrol and its derivatives on internucleosomal DNA fragmentation in HL-60 cells
The relative apoptosis-inducing ability as assessed by agarose gel electrophoresis is shown in Fig. 4 . The result indicates that among celastrol and its derivatives tested, celastrol was the most potent agent. Reduction of ketone at the C-2 position of celastrol to produce cela-H induced apoptosis signiˆcantly but it was less potent than celastrol. The other derivatives was not able to induce DNA fragmentation. When HL-60 is cultured in the presence of either celastrol or etoposide at the same concentration for 6 h, the former was able to induce apoptosis more strongly than the latter (Data not shown).
Celastrol and cela-H were able to inhibit topoisomerase II activity
Finally, we addressed the question whether celastrol can inhibit the enzymic activity of topoisomerase II. For this purpose, an anticancer drug, etoposide, a well-known speciˆc inhibitor of topoisomerase II, was used as a control. As clearly shown in Table 1 , it inhibited topoisomerase II with 7.41±1.12 mM of IC50, indicating that celastrol is a more potent inhibitor than etoposide (30.32±1.14 mM IC 50 ). Additionally cela-H, another apoptosis inducer (Fig. 4) , could inhibit topoisomerase II as potently as etoposide.
Discussion
Celastrol has antiin‰ammatory and antitumor activities.
7)
The mechanisms of these eŠects, however, are poorly understood. Herein, this report describes the discovery of celastrol as a potent inducer of apoptosis (Figs. 2 and 3) . As to the structural basis of potent apoptosis inducing activity, the rank order of the activity was celastrolÀcela-H:the other derivatives＝vehicle control (Fig. 4) . These The inhibitory activity for topoisomerase II was measured by the method described in Materials and Methods. Data were expressed as means±SE of three diŠerent determinations. Etoposide is a speciˆc inhibitor of topoisomerase II. data suggest that, at least, modiˆcations at C-6, C-21, C-22, and C-23 in the celastrol structure could reduce the ability of celastrol to induce apoptosis. Furthermore, the structure from C-1 to C-10 of celastrol, including the double bond between C-7 and C-8, is important to the apoptosis inducing activity.
We indicated that celastrol inhibited topoisomerase II activity more strongly than etoposide, an inhibitor of topoisomerase II ( Table 1 ). The inhibitory activities of celastrol and cela-H on topoisomerase II corresponded to inducing activities of these compounds on apoptosis (Fig. 4) , indicating that the apoptosis induction by celastrol may be caused by the inhibition of topoisomerase II.
As mentioned in the introduction, celastrol has an activity to inhibit lipid peroxidation in vitro. 3, 4) In some experimental systems, it is reported that lipid peroxidation is associated with apoptosis. 15, 16) On the contrary, an interesting paper supporting a correlation between antioxidation activity and apoptosis has appeared. 17) However, further investigation remains to clarify whether the antioxidative eŠect of celastrol is associated with the apoptosis.
